Reuters logo
BRIEF-Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe
January 2, 2017 / 7:07 AM / in a year

BRIEF-Sanofi Pasteur and MSD confirm ending of joint vaccines business in Europe

Jan 2 (Reuters) - Sanofi :

* Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co. Inc., in the United States and Canada), Sanofi Pasteur MSD (SPMSD).

* Sanofi SA and Merck & Co Inc had previously said in March that they would end a 22-year-old joint venture to sell vaccines in Europe, arguing they would do better by managing their product portfolios independently.

Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below